Fagron SA/ BE0003874915 /
9/11/2024 12:39:46 PM | Chg. +0.040 | Volume | Bid2:02:23 PM | Ask2:01:12 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
19.160EUR | +0.21% | 4,523 Turnover: 86,787.040 |
19.160Bid Size: 442 | 19.200Ask Size: 363 | 1.4 bill.EUR | 1.57% | 19.75 |
GlobeNewswire
1/30
MasterControl Launches Advanced Quality Event Management Software to Streamline Quality Processes
GlobeNewswire
10/7/2021
MasterControl Honors Customers’ Success in Quality and Innovation at the Annual Masters of Excellen...
GlobeNewswire
3/23/2021
Fagron Expands Use of MasterControl’s Quality Excellence to 8 European Sites
GlobeNewswire
6/26/2019
Fagron NV: Fagron reaches settlement in principle with US Department of Justice
GlobeNewswire
6/3/2019
U.S. Compounding Pharmacies Market is Expected to Reach Around US$ 14 Bn by the End of 2028 – Future...
GlobeNewswire
2/7/2019
Fagron realized turnover growth of 14.5%; REBITDA increased to € 99.1 million
GlobeNewswire
10/11/2018
Fagron continues strong turnover growth of first semester in the third quarter of 2018
GlobeNewswire
9/18/2018
Compounding Pharmacies Market to Reach US$ 13,366.5 Mn by 2025 – Persistence Market Research
GlobeNewswire
7/12/2018
Sequana Medical Announces the Appointment of Kirsten Van Bockstaele as Chief Financial Officer
GlobeNewswire
4/13/2018
Fagron NV: Convocation annual general meeting and extraordinary general meeting